BARCLAYS PLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2021$21,000
+31.2%
5,989
+17.9%
0.00%
Q2 2021$16,000
-87.5%
5,081
-86.3%
0.00%
Q1 2021$128,000
+141.5%
37,138
+76.0%
0.00%
Q4 2020$53,000
+26.2%
21,101
+4.1%
0.00%
Q3 2020$42,000
-22.2%
20,275
-16.8%
0.00%
Q2 2020$54,000
+45.9%
24,362
+66.8%
0.00%
Q1 2020$37,000
-68.6%
14,608
-67.5%
0.00%
Q4 2019$118,000
+43.9%
44,979
+96.3%
0.00%
Q3 2019$82,000
-17.2%
22,912
-22.0%
0.00%
Q2 2019$99,000
+191.2%
29,365
+135.9%
0.00%
Q1 2019$34,00012,446
+19974.2%
0.00%
Q4 2018$0
-100.0%
62
-99.6%
0.00%
Q3 2018$70,000
+337.5%
17,102
+430.5%
0.00%
Q2 2018$16,000
-72.9%
3,224
-69.4%
0.00%
Q1 2018$59,000
-62.2%
10,534
-44.9%
0.00%
Q4 2017$156,000
-18.3%
19,129
+5.4%
0.00%
Q3 2017$191,000
-47.1%
18,157
-44.7%
0.00%
Q2 2017$361,000
+99.4%
32,834
+52.4%
0.00%
Q1 2017$181,000
-67.0%
21,546
-72.7%
0.00%
-100.0%
Q4 2016$548,000
+26.6%
79,000
-7.2%
0.00%
Q3 2016$433,000
+19.6%
85,144
+40.3%
0.00%
Q2 2016$362,000
+52.7%
60,680
+2.3%
0.00%
Q1 2016$237,00059,300
+92556.2%
0.00%
Q4 2015$0
-100.0%
64
-99.1%
0.00%
Q3 2015$21,000
+950.0%
7,100
+510.5%
0.00%
Q1 2015$2,000
-75.0%
1,163
-44.4%
0.00%
Q4 2014$8,000
-33.3%
2,092
-6.7%
0.00%
Q3 2014$12,000
+200.0%
2,243
+186.8%
0.00%
Q2 2014$4,000782
+956.8%
0.00%
Q1 2014$0
-100.0%
74
-99.7%
0.00%
Q4 2013$52,000
+300.0%
26,170
+297.1%
0.00%
Q3 2013$13,000
-48.0%
6,590
-46.2%
0.00%
Q2 2013$25,00012,2450.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2019
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,736,719$9,414,00013.61%
HARBERT FUND ADVISORS, INC. 5,175,913$17,805,0008.40%
Evermore Global Advisors, LLC 2,605,607$8,963,0006.32%
KEMPNER CAPITAL MANAGEMENT INC. 95,476$328,0000.19%
CORRADO ADVISORS, LLC 46,816$161,0000.12%
MYDA Advisors LLC 35,000$120,0000.03%
Cutter & CO Brokerage, Inc. 29,827$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 258,700$890,0000.02%
Paradigm Financial Partners, LLC 18,000$62,0000.02%
Renaissance Technologies 3,340,864$11,493,0000.01%
View complete list of ENZO BIOCHEM INC shareholders